COLL - Collegium Pharmaceutical EPS misses by $0.03 misses on revenue November, 06 2019 04:26 PM Collegium Pharmaceutical Inc. Collegium Pharmaceutical (NASDAQ:COLL): Q3 GAAP EPS of -$0.18 misses by $0.03.More news on: Collegium Pharmaceutical, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...